Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: hMSCs for ARDS
NCT02097641Phase 2Completed
- Start
- Mar 2014
- Primary completion
- Mar 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic bone marrow-derived human mesenchymal stromal cells in acute respiratory distress syndrome (ARDS). Started Mar 2014; status: completed.
02
Drugs
allogeneic bone marrow-derived human mesenchymal stromal cells
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02097641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097641.